Illinois Municipal Retirement Fund Sells 18,562 Shares of Agilent Technologies, Inc. (NYSE:A)

Illinois Municipal Retirement Fund lessened its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 29.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,907 shares of the medical research company's stock after selling 18,562 shares during the period. Illinois Municipal Retirement Fund's holdings in Agilent Technologies were worth $5,136,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Stone Summit Wealth LLC acquired a new stake in Agilent Technologies during the 1st quarter valued at $2,530,000. KPP Advisory Services LLC raised its holdings in shares of Agilent Technologies by 9.8% during the first quarter. KPP Advisory Services LLC now owns 3,356 shares of the medical research company's stock valued at $393,000 after buying an additional 300 shares during the last quarter. Penobscot Investment Management Company Inc. increased its position in Agilent Technologies by 13.8% in the 1st quarter. Penobscot Investment Management Company Inc. now owns 23,115 shares of the medical research company's stock valued at $2,704,000 after acquiring an additional 2,810 shares during the period. Robeco Institutional Asset Management B.V. boosted its position in Agilent Technologies by 2.1% during the 1st quarter. Robeco Institutional Asset Management B.V. now owns 78,679 shares of the medical research company's stock worth $9,204,000 after acquiring an additional 1,614 shares during the period. Finally, Sequoia Financial Advisors LLC raised its stake in shares of Agilent Technologies by 3.3% during the first quarter. Sequoia Financial Advisors LLC now owns 35,004 shares of the medical research company's stock valued at $4,095,000 after purchasing an additional 1,106 shares in the last quarter.

Agilent Technologies Stock Up 0.0%

Shares of NYSE:A traded up $0.05 on Wednesday, reaching $120.50. The company had a trading volume of 844,803 shares, compared to its average volume of 1,844,294. The stock has a 50-day moving average price of $112.89 and a 200 day moving average price of $123.51. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The stock has a market capitalization of $34.23 billion, a P/E ratio of 29.83, a P/E/G ratio of 3.58 and a beta of 1.23.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. Agilent Technologies's revenue was up 6.0% compared to the same quarter last year. During the same period last year, the business posted $1.22 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be given a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 annualized dividend and a yield of 0.82%. Agilent Technologies's dividend payout ratio is 24.44%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on A. Jefferies Financial Group reduced their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research note on Monday, April 21st. Leerink Partners upped their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a report on Friday, May 30th. Barclays upped their price target on Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a report on Tuesday, June 24th. Robert W. Baird dropped their price target on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research note on Thursday, May 22nd. Finally, TD Cowen boosted their price target on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of "Moderate Buy" and an average target price of $140.92.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.